Atria Wealth Solutions Inc. Trims Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Atria Wealth Solutions Inc. decreased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 40,981 shares of the financial services provider’s stock after selling 2,115 shares during the quarter. Atria Wealth Solutions Inc. owned about 0.07% of iShares Biotechnology ETF worth $5,567,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in IBB. International Assets Investment Management LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter valued at $76,425,000. Itau Unibanco Holding S.A. purchased a new stake in iShares Biotechnology ETF in the third quarter valued at $48,242,000. Tower Research Capital LLC TRC raised its position in iShares Biotechnology ETF by 28,138.4% in the third quarter. Tower Research Capital LLC TRC now owns 98,552 shares of the financial services provider’s stock valued at $12,052,000 after purchasing an additional 98,203 shares during the period. Calamos Advisors LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter valued at $7,648,000. Finally, Cumberland Advisors Inc. purchased a new stake in iShares Biotechnology ETF in the third quarter valued at $6,297,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $126.49 on Friday. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16. The stock’s fifty day moving average is $134.45 and its two-hundred day moving average is $129.71.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.